Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.47 USD | +1.41% | -4.84% | -30.03% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.